Round 26 of COVID-19 Vaccine Booking Starts August 23
Taipei City Government’s 26th Round of COVID-19 Vaccine Booking will be available between August 23 and 26. The public can access the registration platform between 9 AM and 9 PM during the aforementioned dates.
Those who sign up can have schedule their appointment dates between August 27 and September 4. The choices of vaccine include: Moderna vaccine for children and teens; Pfizer-BioNTech (BNT) vaccine for children and teens; Moderna vaccine; BNT vaccine; NOVAVAX vaccine, and MVC vaccine.
Furthermore, to ensure the vaccination rights of 12 to 17 years old teens, the BNT vaccine available during the current round will be reserved for the aforementioned recipients for shots including: primary series shot 1, primary series shot 2, and booster shot 1. Bookings for BNT vaccine may open up to other groups depending on actual inventory and supply volumes.
In addition, partner hospitals across the city have roughly 20,000 slots available for vaccine outpatient clinic reservation. For details, please check Taipei City’s Vaccine Information Website in Chinese (https://reurl.cc/o1Y8Vv).
The first batch of BNT vaccine for children and teens will be administered at Taipei City Hospital Women’s and Children’s Branch, Yangming Branch, Taipei Stadium Vaccination Site, and McKay Hospital starting August 27. Eligible individuals can reserve a slot via the 26th round of vaccine booking system.
The Department of Health pointed out that research indicates the chances of children with COVID-19 developing MIS-C (Multisystem Inflammatory Syndrome in Children) is lowered by 90% for those who are fully vaccinated. With the increase of domestic BA.4 and BA.5 infections, families with kids older than 6 months are encouraged to have them vaccinated before the autumn and winter season.
The agency also reminded those under the age of 12 who have yet to receive any shots and adults above 50 who have not received their second booster shot to get them as soon as possible to minimize the chance of developing severe complications in the case of COVID infection.